Comment on: “Combination of immunotherapy-based systemic therapy and radiotherapy achieves durable response and favorable survival in recurrent head and neck cancer”
Erkan Topkan, Efsun Somay, Ugur Selek · 2026
Read Comment on: “Combination of immunotherapy-based systemic therapy and radiotherapy achieves durable response and favorable survival in recurrent head and neck cancer” by Erkan Topkan, Efsun Somay, Ugur Selek (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13424761.txt.
Description
Erkan Topkan, Efsun Somay, and Ugur Selek write a letter commenting on a study of recurrent head and neck cancer. That study combined immune checkpoint drugs with focused radiation. The correspondents praise its results while challenging how survival was clocked. The original cohort was small, twenty-three patients, yet twenty responded and every patient was alive at one year.
The correspondents' concern is comparability. The study timed overall survival from recurrence diagnosis. International conventions start the clock at treatment initiation or randomisation instead. Progression-free survival should likewise run from treatment start. Mixed definitions, they argue, make cross-study comparison treacherous and can flatter results. Their letter asks for standardised endpoints so encouraging findings can be judged fairly against other series.
Catalog record
| CREATOR | Erkan Topkan, Efsun Somay, Ugur Selek |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 7 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |